The world's good news, every day.

RSS

Health

Britain Orders a Brain Cancer Review and a Faster Path to New Treatments After Swimmer Archie Goodburn's Plea

After meeting Archie Goodburn, a 25-year-old swimmer with inoperable brain cancer, Prime Minister Andy Burnham set out four steps on 14 October: an expert review led by Professor Anthony Chalmers reporting within three months, a national action plan, a national brain cancer clinical lead and a faster review of the rules on rare-disease medicines.

Just News Desk, Correspondent||5 min read

The black front door of 10 Downing Street in London, 2020. Photo: UK Government, via Wikimedia Commons (Open Government Licence v3.0). Source page: https://commons.wikimedia.org/wiki/File:10_Downing_Street_Door_2020.jpg
The black front door of 10 Downing Street in London, 2020. Photo: UK Government, via Wikimedia Commons (Open Government Licence v3.0). Source page: https://commons.wikimedia.org/wiki/File:10_Downing_Street_Door_2020.jpg

LONDON - The British government has ordered an immediate expert review of progress against brain cancer, due to report within three months, after Prime Minister Andy Burnham and Health and Social Care Secretary Yvette Cooper met Archie Goodburn, a 25-year-old swimmer with inoperable brain cancer, in Downing Street on 14 October. The review, led by Professor Anthony Chalmers, is the first of four steps that the Prime Minister's Office said would give people living with brain cancer "a faster route from research to treatment."

Mr. Goodburn had made what the government described as an emotional plea to the Prime Minister on BBC Breakfast, and he has campaigned for faster progress against the disease. The measures announced on Wednesday, the Prime Minister's Office said, build on the issues he raised.

The black front door of 10 Downing Street, with its brass number 10, letterbox and lion's-head knocker, set in a dark brick facade.

The front door of 10 Downing Street in London, where Archie Goodburn met the Prime Minister and the Health and Social Care Secretary on 14 October 2026. Photo: UK Government, 2020, via Wikimedia Commons (Open Government Licence v3.0). Source page: https://commons.wikimedia.org/wiki/File:10_Downing_Street_Door_2020.jpg

Professor Chalmers, who chairs the Brain Tumour Group within the UK Collaborative for Cancer Clinical Research, will lead a panel of brain cancer experts assessing what has changed for patients since a government review in 2018, and "what is still holding progress back," according to the announcement. Its findings will shape a national action plan intended to get new treatments "out of the lab and to patients faster." The findings will also be shared with the All-Party Parliamentary Group on Brain Tumours and with brain cancer charities.

The Department of Health and Social Care will appoint a new national brain cancer clinical lead to drive the work forward, and the department said it would announce the appointment in due course. In the fourth step, the Prime Minister has asked the Medicines and Healthcare products Regulatory Agency to complete its review of the rules for medicines that treat rare conditions, known as orphan drugs, in two years rather than three. That review is required by the Rare Cancers Act 2026, and bringing forward any changes, the government said, could help patients reach promising new treatments sooner.

A smiling man with dark hair and dark-rimmed glasses, in a dark jacket, photographed indoors against a wood-paneled background.

Andy Burnham, photographed on 13 August 2024, when he was Mayor of Greater Manchester. He is now Prime Minister. Photo: Scottish Government, via Flickr and Wikimedia Commons (CC BY 2.0). Source page: https://commons.wikimedia.org/wiki/File:Andy_Burnham_on_13_August_2024_(cropped_2).jpg

"He has spoken passionately about the need for change on brain cancer, and he's right: progress hasn't been good enough, here or anywhere else. Families facing this disease can't afford to wait," Mr. Burnham said in the statement. "Archie is an inspiration to us all, and I am determined to deliver the change patients and their families deserve."

Alongside the four steps, patients, families and charities will help design a drive to enroll more people in clinical trials. Ms. Cooper will lead that effort and host a roundtable with researchers, clinicians and charities to find new ways to raise participation. Next year, the Department of Health and Social Care will partner with Cancer Research UK to bring together global experts in brain cancer research. The National Institute for Health and Care Research is currently supporting 59 brain tumour studies across the country, including 35 clinical trials of new treatments, according to the announcement.

"Archie has shown extraordinary courage in speaking out and fighting for everyone affected by brain cancer," Ms. Cooper said. "We owe it to every family facing this devastating disease to do better."

A grid of grayscale CT and MRI brain scans showing a lesion in the right frontal lobe, labeled A through D.

CT and MRI scans of a biopsy-proven right frontal lobe oligodendroglioma in a 38-year-old patient, published in a 2022 review of brain tumour imaging. The scans do not show Mr. Goodburn. Images: Saivenkat Vagvala, Jeffrey P. Guenette, Camilo Jaimes and Raymond Y. Huang, "Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics," Cancer Imaging 22, 19 (2022), via Wikimedia Commons (CC BY 4.0). Source page: https://commons.wikimedia.org/wiki/File:Oligodendroglioma_CT_%26_MRI.webp

Mr. Goodburn, who reached the final of the 50-meter breaststroke at the 2026 Commonwealth Games in Glasgow, was diagnosed with three oligodendrogliomas, a rare type of tumour, after experiencing numbness and seizures while training for the 2024 Olympic trials, the BBC reported. He has received chemotherapy and radiotherapy, but surgery to remove the tumours was found to be impossible.

After the meeting, he told the BBC that all three of his requests had been promised to some extent. "There is some fleshing out that needs to be done on the details," he said. "I don't think I could ask for much more at this point so I sent a very strong thanks to Andy Burnham for his time."

Five charities, Brainstrust, Brain Tumour Research, Brain Tumour Support, The Brain Tumour Charity and The Tessa Jowell Foundation, along with The Tessa Jowell Brain Cancer Mission, thanked Mr. Goodburn for his determination and the government "for listening to the voices of the community and recognising the urgent need for change." Michelle Mitchell, chief executive of Cancer Research UK, called the announcements "an important step towards accelerating progress."

A smiling woman with short gray hair, in a burgundy jacket, in a formal portrait against a plain gray background.

Yvette Cooper in an official cabinet portrait taken at 10 Downing Street on 5 September 2025, the day she was appointed Foreign Secretary. She is now Health and Social Care Secretary. Photo: Lauren Hurley / No 10 Downing Street, via Wikimedia Commons (Open Government Licence v3.0). Source page: https://commons.wikimedia.org/wiki/File:Yvette_Cooper_Official_Cabinet_Portrait,_September_2025.jpg

The government's own figures set out the stakes. In England in 2023, 3,792 people died of malignant brain cancer, 278 of them under the age of 40, according to data published with the announcement.

The primary record is the Prime Minister's Office, 10 Downing Street, press release of 14 October 2026, "Brain cancer patients to see faster development of new treatments" (https://www.gov.uk/government/news/brain-cancer-patients-to-see-faster-development-of-new-treatments). Mr. Goodburn's remarks and biographical details are from BBC News coverage of the same day (https://www.bbc.co.uk/news/articles/cm74pn052j2vo). Photographs of the Downing Street meeting are owned by news agencies and are not reproduced here; the images above are Wikimedia Commons files with the licenses noted.

  • health
  • cancer
  • brain-cancer
  • clinical-trials
  • united-kingdom
  • policy
The main entrance of FDA Building 1 on the White Oak campus in Silver Spring, Maryland, which houses the commissioner's and senior staff offices. Photo: U.S. Food and Drug Administration, via Wikimedia Commons (public domain). Source page: https://commons.wikimedia.org/wiki/File:FDA_Bldg_1_-_Exterior_With_Circle_(5161374950).jpg

Health

FDA Approves a Tucatinib Maintenance Regimen for Advanced HER2-Positive Breast Cancer

On 7 October 2026 the FDA approved tucatinib with trastuzumab and pertuzumab as maintenance therapy for adults with unresectable locally advanced or metastatic HER2-positive breast cancer after induction treatment, based on longer progression-free survival in the HER2CLIMB-05 trial. Overall survival data were not yet mature, and the label carries warnings that include diarrhea and hepatotoxicity.

Just News Desk · 14 October 2026

The morning briefing

A handful of hopeful stories, once a week.

No doomscroll. No ads sold against your attention. Just the week’s brightest, most carefully reported pieces — in one letter.